AMLo Biosciences
Company Details
Status: Private
Employees: 11-50
Location:
The Biosphere, Newcastle Helix, Drayman's Way, Newcastle upon Tyne, Northumberland NE4 5BX, GB
Type:
sample
Technology:
sample
About: Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients' true risk of disease progression. Those patients who are genuinely at low-risk of disease spread can be provided reassurance and better-informed follow-up care, while those identified at risk of metastasis are enabled to receive timely treatment.
The test under development – AMBLor® – will be simple to use and fits seamlessly into current diagnostic practice. AMLo Biosciences has been founded by a team with an internationally acclaimed research track record in the melanoma field, through identification of translational biomarkers, drug discovery & development and the building of biotech companies.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
AMLo Biosciences | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.